ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of a Topical Vasodilating Cream on Female Sexual Experience (TVConFSD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01078077
Recruitment Status : Unknown
Verified March 2012 by Michael Pelekanos MD, East Suburban Ob Gyn.
Recruitment status was:  Recruiting
First Posted : March 2, 2010
Last Update Posted : March 2, 2012
Sponsor:
Collaborator:
West Penn Allegheny Health System
Information provided by (Responsible Party):
Michael Pelekanos MD, East Suburban Ob Gyn

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Condition or disease
Female Sexual Dysfunction

Detailed Description:
To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Impact of a Topical Vasodilating Cream (When Applied to the Clitoris) on the Female Sexual Experience Using a Standard 7 Part Female Sexual Dysfunction Questionnaire
Study Start Date : March 2010
Actual Primary Completion Date : March 2012
Estimated Study Completion Date : July 2012
Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   25 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Sexually active females from ages 25 to sixty not on SSRI's without neurologic disease able sign and understand informed consent
Criteria

Inclusion Criteria:

  • Healthy females ages 25 to sixty sexually active

Exclusion Criteria:

  • Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01078077


Contacts
Contact: michael j pelekanos, MD 4128567500 mipels@aol.com
Contact: Guy Stofman, MD 4123706313 guystof@aol.com

Locations
United States, Pennsylvania
East Suburban Obgyn Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: Michael J Pelekanos, MD    412-779-1034    mipels@aol.com   
Contact: Guy Stoffman, MD    412 3706313    guystof@aol.com   
Principal Investigator: Michael J Pelekanos, MD         
West Penn Allegheny Health Center Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: pelekanos    412-856-7500      
Contact: vickie lathom    4128567500      
Principal Investigator: michael j pelekanos, md         
West Penn Hospital Forbes Campus Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: michael j pelekanos, md    412-856-7500    mipels@aol.com   
Principal Investigator: michael j pelekanos, md         
Sponsors and Collaborators
Michael Pelekanos MD
West Penn Allegheny Health System
Investigators
Principal Investigator: michael j pelekanos, MD east surburban obgyn
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Michael Pelekanos MD, michael pelekanos MD, WPAHS, East Suburban Ob Gyn
ClinicalTrials.gov Identifier: NCT01078077     History of Changes
Other Study ID Numbers: 10-005
First Posted: March 2, 2010    Key Record Dates
Last Update Posted: March 2, 2012
Last Verified: March 2012

Keywords provided by Michael Pelekanos MD, East Suburban Ob Gyn:
healthy females ages twentyfive through sixty